These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 16204787

  • 1. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ, Demkow U, Górecka D, de Backer WA, Zielinski J.
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
    [Abstract] [Full Text] [Related]

  • 2. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ, Bathoorn E, Postma DS, Vonk JM, Timens W, Kerstjens HA.
    Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
    [Abstract] [Full Text] [Related]

  • 3. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant.
    Sadowska AM, van Overveld FJ, Górecka D, Zdral A, Filewska M, Demkow UA, Luyten C, Saenen E, Zielinski J, De Backer WA.
    Respir Med; 2005 Feb; 99(2):241-9. PubMed ID: 15715193
    [Abstract] [Full Text] [Related]

  • 4. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM, Rice KL, Janoff EN, Rector TS, Niewoehner DE.
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of budesonide on inflammatory status in COPD.
    Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE.
    COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
    [Abstract] [Full Text] [Related]

  • 6. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis.
    Schermer T, Chavannes N, Dekhuijzen R, Wouters E, Muris J, Akkermans R, van Schayck O, van Weel C.
    Respir Med; 2009 Apr; 103(4):542-51. PubMed ID: 19138505
    [Abstract] [Full Text] [Related]

  • 7. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C.
    Eur J Gen Pract; 2007 Apr; 13(2):89-91. PubMed ID: 17534745
    [Abstract] [Full Text] [Related]

  • 8. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML, Bussamra MH, Saraiva-Romanholo BM, Martins MA, Okay TS, Rodrigues JC.
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [Abstract] [Full Text] [Related]

  • 9. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
    Zietkowski Z, Kucharewicz I, Bodzenta-Lukaszyk A.
    Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
    [Abstract] [Full Text] [Related]

  • 10. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
    Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P.
    Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
    [Abstract] [Full Text] [Related]

  • 11. Differences in responses upon corticosteroid therapy between smoking and non-smoking patients with COPD.
    Van Overveld FJ, Demkow U, Górecka D, De Backer WA, Zieliński J.
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():273-82. PubMed ID: 17072055
    [Abstract] [Full Text] [Related]

  • 12. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L, Cai BQ, Zhu YJ.
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [Abstract] [Full Text] [Related]

  • 14. Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD.
    Dal Negro R, Visconti M, Trevisan F, Bertacco S, Micheletto C, Tognella S.
    Ther Adv Respir Dis; 2008 Oct; 2(5):271-7. PubMed ID: 19124377
    [Abstract] [Full Text] [Related]

  • 15. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
    Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD.
    Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacological treatment of COPD and future of anti-inflammatory therapy].
    Watz H, Bitter-Suermann S, Kanniess F, Magnussen H.
    Med Klin (Munich); 2006 Apr 15; 101(4):283-92. PubMed ID: 16607484
    [Abstract] [Full Text] [Related]

  • 17. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?
    Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, Hayot M, Prefaut C.
    Am J Respir Crit Care Med; 2004 May 01; 169(9):1022-7. PubMed ID: 15001462
    [Abstract] [Full Text] [Related]

  • 18. High-dose N-acetylcysteine in the prevention of COPD exacerbations: rationale and design of the PANTHEON Study.
    Zheng JP, Wen FQ, Bai CX, Wan HY, Kang J, Chen P, Yao WZ, Ma LJ, Xia QK, Gao Y, Zhong NS, PANTHEON study committee.
    COPD; 2013 Apr 01; 10(2):164-71. PubMed ID: 23061828
    [Abstract] [Full Text] [Related]

  • 19. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
    Kasielski M, Nowak D.
    Respir Med; 2001 Jun 01; 95(6):448-56. PubMed ID: 11421501
    [Abstract] [Full Text] [Related]

  • 20. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L, Bertella E, La Piana GE, Boni E, Redolfi S, Tantucci C.
    Respiration; 2008 Jun 01; 76(1):61-8. PubMed ID: 18319586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.